| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adverse effects of pertussis and rubella vaccines
|
Parton, R.
|
|
1993
|
11 |
13 |
p. 1366-
1 p.
|
artikel
|
| 2 |
Avridine and LPS from Brucella ovis: Effect on the memory induced by foot-and-mouth disease virus vaccination in mice
|
Berinstein, A.
|
|
1993
|
11 |
13 |
p. 1295-1301
7 p.
|
artikel
|
| 3 |
Bicistronic eukaryotic RNA virus expressing heterologous polypeptide; polio virus vector with encephalomyocarditis virus ribosome landing pad for use in recombinant vaccine or recombinant protein production in eukaryote cell
|
|
|
1993
|
11 |
13 |
p. 1357-
1 p.
|
artikel
|
| 4 |
Calendar
|
|
|
1993
|
11 |
13 |
p. 1368-
1 p.
|
artikel
|
| 5 |
Co-dominant and reciprocal T-helper cell activity of epitopic sequences and formation of junctional B-cell determinants in synthetic T:B chimeric immunogens
|
Sharma, Pawan
|
|
1993
|
11 |
13 |
p. 1321-1326
6 p.
|
artikel
|
| 6 |
Control of capripoxvirus infections
|
Carn, V.M.
|
|
1993
|
11 |
13 |
p. 1275-1279
5 p.
|
artikel
|
| 7 |
Efficacy of Brucella suis strain 2 vaccine against Brucella ovis in rams
|
Blasco, J.M.
|
|
1993
|
11 |
13 |
p. 1291-1294
4 p.
|
artikel
|
| 8 |
Immunopotentiation of local and systemic humoral immune responses by ISCOMs, liposomes and FCA: role in protection against influenza A in mice
|
Ahmeida, E.T.S.Ben
|
|
1993
|
11 |
13 |
p. 1302-1309
8 p.
|
artikel
|
| 9 |
Improved immunogenicity of recombinant vaccinia virus-anchored gp120 lacking gp41
|
Jin, Y.
|
|
1993
|
11 |
13 |
p. 1280-1282
3 p.
|
artikel
|
| 10 |
Induction of cytolytic and antibody responses using Plasmodium falciparum repeatless circumsporozoite protein encapsulated in liposomes
|
White, Katherine
|
|
1993
|
11 |
13 |
p. 1341-1346
6 p.
|
artikel
|
| 11 |
Killed Campylobacter elicits immune response and protection when administered with an oral adjuvant
|
Rollwagen, Florence M.
|
|
1993
|
11 |
13 |
p. 1316-1320
5 p.
|
artikel
|
| 12 |
Mass vaccination for hepatitis B in Italy: Physiopathological, epidemiological and socioeconomic foundations
|
Assael, Dr
|
|
1993
|
11 |
13 |
p. 1365-1366
2 p.
|
artikel
|
| 13 |
New protein containing an antigenic site of a prion protein; prepared by DNA sequence expression and useful for diagnosis and therapy of mammalian encephalopathy, e.g. Creutzfeld-Jakob disease and as a recombinant vaccine
|
|
|
1993
|
11 |
13 |
p. 1356-
1 p.
|
artikel
|
| 14 |
Oral immunization with recombinant BCG induces cellular and humoral immune responses against the foreign antigen
|
Lagranderie, M.
|
|
1993
|
11 |
13 |
p. 1283-1290
8 p.
|
artikel
|
| 15 |
Passively transferred antibodies directed against conserved regions of SIV envelope protect macaques from SIV infection
|
Lewis, Mark G.
|
|
1993
|
11 |
13 |
p. 1347-1355
9 p.
|
artikel
|
| 16 |
Peptide comprising human T-lymphocyte epitope of circumsporozoite protein of Plasmodium vivax; recombinant protein useful in malaria diagnosis and as a recombinant vaccine; monoclonal antibody
|
|
|
1993
|
11 |
13 |
p. 1357-
1 p.
|
artikel
|
| 17 |
Peptide sequences with strong stimulatory activity for lymphoid cells: implications for vaccine development
|
Russell-Jones, Gregory J.
|
|
1993
|
11 |
13 |
p. 1310-1315
6 p.
|
artikel
|
| 18 |
Pneumocystis carinii recombinant major surface antigen production; for use in recombinant vaccine production and in diagnosis of P. carinii infection in AIDS patient
|
|
|
1993
|
11 |
13 |
p. 1357-
1 p.
|
artikel
|
| 19 |
Production of recombinant virus vector; vaccinia virus, herpes virus and baculovirus vector construction by direct in vitro ligation; potential recombinant vaccine vector
|
|
|
1993
|
11 |
13 |
p. 1356-
1 p.
|
artikel
|
| 20 |
Protein for use in recombinant vaccine against Chlamydia trachomatis infection; containing a conserved T-lymphocyte helper cell stimulating epitope and a neutralizing B-lymphocyte epitope
|
|
|
1993
|
11 |
13 |
p. 1356-
1 p.
|
artikel
|
| 21 |
Quantitative and qualitative analysis of anti-tetanus toxoid antibody response in the elderly. Humoral immune response enhancement by thymostimulin
|
Fagiolo, U.
|
|
1993
|
11 |
13 |
p. 1336-1340
5 p.
|
artikel
|
| 22 |
Recombinant DNA encoding Pseudomonas exotoxin and influenza A virus or HIV virus-1 surface antigen fusion protein; recombinant protein cell display and use as a vaccine against parasite and virus infection and tumour growth
|
|
|
1993
|
11 |
13 |
p. 1357-
1 p.
|
artikel
|
| 23 |
Recombinant Sabin or Mahoney polio virus with artificial proteolytic cleavage site encoded by DNA sequence and RNA sequence; application as a vaccine as vector and for exogenous protein production in tissue culture
|
|
|
1993
|
11 |
13 |
p. 1356-
1 p.
|
artikel
|
| 24 |
Scarification with a vaccinia—influenza recombinant does not stimulate IgA unless the animals auto- or cross-inoculate their nasopharynxes
|
Meitin, Catherine A.
|
|
1993
|
11 |
13 |
p. 1360-1361
2 p.
|
artikel
|
| 25 |
Serious hepatitis B vaccine adverse reactions, are they immune-mediated?
|
Carmeli, Yehuda
|
|
1993
|
11 |
13 |
p. 1358-1359
2 p.
|
artikel
|
| 26 |
Use of the Vibrio cholerae irgA gene as a locus for insertion and expression of heterologous antigens in cholera vaccine strains
|
Butterton, Joan R.
|
|
1993
|
11 |
13 |
p. 1327-1335
9 p.
|
artikel
|
| 27 |
Vaccines for veterinary applications
|
Spier, R.E.
|
|
1993
|
11 |
13 |
p. 1366-1367
2 p.
|
artikel
|
| 28 |
Vaccines: New technologies and applications
|
Edelman, Robert
|
|
1993
|
11 |
13 |
p. 1361-1364
4 p.
|
artikel
|
Tijdschrift beschrijving